Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 6/20 | 0.66 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.48 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.48 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.48 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5667215 | 0.94 | LTA4H (0.65) | LTA4HFFAR1HSD11B1ALDH1A1HSD17B10 | |
| SCHEMBL4546800 | 0.92 | LTA4H (0.62) | LTA4HFFAR1ALDH1A1HSD17B10 | |
| SCHEMBL16558294 | 0.92 | LTA4H (0.62) | LTA4HFFAR1ALDH1A1HSD17B10 | |
| SCHEMBL15312061 | 0.92 | LTA4H (0.62) | LTA4HFFAR1ALDH1A1HSD17B10 | |
| SCHEMBL12721515 | 0.92 | LTA4H (0.62) | LTA4HFFAR1ALDH1A1HSD17B10 | |
| SCHEMBL12056748 | 0.92 | LTA4H (0.62) | LTA4HFFAR1ALDH1A1HSD17B10 | |
| SCHEMBL145761 | 0.92 | LTA4H (0.52) | LTA4HALDH1A1HPGDHSD17B10 | |
| SCHEMBL2453789 | 0.91 | LTA4H (0.61) | LTA4HFFAR1ALDH1A1HSD17B10 | |
| SCHEMBL10630392 | 0.91 | LTA4H (0.61) | LTA4HFFAR1ALDH1A1HSD17B10 | |
| SCHEMBL427538 | 0.88 | LTA4H (0.59) | LTA4HFFAR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003002072-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'ORÉAL (FR) | 2003-01-09 | — | — | WO | claimed |
| CN-122055371-A | Faster automated iterative C-C bond formation | 伊利诺伊大学评议会 | 2026-05-15 | — | — | CN | disclosed |
| WO-2025042679-A1 | FASTER AUTOMATED ITERATIVE C-C BOND FORMATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2025-02-27 | — | — | WO | disclosed |
| EP-3536683-B1 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2021-11-24 | — | — | EP | disclosed |
| CN-111662314-B | Polycyclic aromatic compound or condensation polymer thereof, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2021-10-26 | — | — | CN | disclosed |
| US-11090325-B2 | Compositions for treating ebola virus infection | REDHILL BIOPHARMA LTD. (IL) | 2021-08-17 | — | — | US | disclosed |
| EP-2832761-B1 | POLYMER COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL CO (JP) | 2020-11-18 | — | — | EP | disclosed |
| CN-106905367-B | Electron transport material or electron injection material, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2020-11-17 | — | — | CN | disclosed |
| CN-111909189-A | Polycyclic aromatic compound, multimer thereof, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2020-11-10 | — | — | CN | disclosed |
| CN-111892615-A | Polycyclic aromatic compound, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2020-11-06 | — | — | CN | disclosed |
| CN-103270079-A | HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL CO | 2013-08-28 | — | — | CN | disclosed |
| WO-2013004190-A1 | AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 中国医学科学院药物研究所 (CN) | 2013-01-10 | — | — | WO | disclosed |
| US-20120270741-A1 | BIOMARKER DISCOVERY IN COMPLEX BIOLOGICAL FLUID USING BEAD OR PARTICLE BASED LIBRARIES AND DIAGNOSTIC KITS AND THERAPEUTICS | OPKO PHARMACEUTICALS, LLC | 2012-10-25 | — | — | US | disclosed |
| US-20120214798-A1 | Novel Ethanediamone Hepcidine Antagonists | VIFOR (INTERNATIONAL) AG (CH) | 2012-08-23 | — | — | US | disclosed |
| US-20120095004-A1 | Sphingosine Kinase Inhibitors | APOGEE BIOTECHNOLOGY CORPORATION (US) | 2012-04-19 | — | — | US | disclosed |
| EP-1354887-B1 | Ligands for metals and improved metal-catalyzed processes based thereon | MASSACHUSETTS INST TECHNOLOGY (US) | 2007-04-25 | — | — | EP | disclosed |
| EP-1097158-B1 | LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-01-25 | — | — | EP | disclosed |
| EP-1354887-A1 | Ligands for metals and improved metal-catalyzed processes based thereon | Massachusetts Insitute of Technology (US) | 2003-10-22 | — | — | EP | disclosed |
| EP-1097158-A2 | LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000002887-A2 | LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095004-A1 | Sphingosine Kinase Inhibitors | SPHK1, SPHK2, S1PR1 | LTA4H 944/4885FFAR1 1162/4885PPARG 3791/4885 |
| US-20120270741-A1 | BIOMARKER DISCOVERY IN COMPLEX BIOLOGICAL FLUID USING BEAD OR PARTICLE BASED LIBRARIES AND DIAGNOSTIC KITS AND THERAPEUTICS | PMP22, TNFSF11, SELPLG | LTA4H 1767/4885FFAR1 1823/4885PPARG 4127/4885 |
| US-20120214798-A1 | Novel Ethanediamone Hepcidine Antagonists | HAMP, SLC40A1, FTH1 | LTA4H 137/4885FFAR1 1215/4885PPARG 1604/4885 |
| US-11090325-B2 | Compositions for treating ebola virus infection | NEFM, EIF2AK2, IRF3 | LTA4H 3461/4885FFAR1 3733/4885PPARG 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.